Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CARM Carisma Therapeutics

盘前交易 12-23 04:31:18 EST

0.4179

-0.0236

-5.35%

最高0.4414	最低0.4053	成交量30.44万
今开0.4350	昨收0.4415	日振幅8.18%
总市值1,745万	流通市值1,263万	总股本4,175万
成交额12.97万	换手率1.01%	流通股本3,022万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics","latestPrice":0.4179,"timestamp":1734728400000,"preClose":0.4415,"halted":0,"volume":304431,"delay":0,"floatShares":30222532,"shares":41750109,"eps":-1.550993,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0236,"latestTime":"12-23 04:31:18 EST","open":0.435,"high":0.4414,"low":0.4053,"amount":129677.468448,"amplitude":0.081767,"askPrice":0.4536,"askSize":100,"bidPrice":0.375,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.550993,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"adjPreClose":0.4179,"postHourTrading":{"tag":"盘后","latestPrice":0.4264,"preClose":0.4179,"latestTime":"19:10 EST","volume":1804,"amount":747.4779,"timestamp":1734739855905},"volumeRatio":0.567467378085949},"requestUrl":"/m/hq/s/CARM","defaultTab":"news","newsList":[{"id":"2492420964","title":"Carisma Therapeutics, Inc.盘中异动 大幅跳水7.97%报0.406美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492420964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492420964?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:51","pubTimestamp":1734706308,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时51分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水7.97%。截至发稿，该股报0.406美元/股，成交量6.5485万股，换手率0.16%，振幅1.45%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220225149a1fe2ebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220225149a1fe2ebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2492871651","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492871651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492871651?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:17","pubTimestamp":1734535077,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时17分，Carisma Therapeutics, Inc.股票出现波动，股价快速上涨5.24%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218231757984cb38d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218231757984cb38d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2492596553","title":"Carisma Therapeutics, Inc.盘中异动 急速下跌5.70%报0.406美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492596553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492596553?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:44","pubTimestamp":1734446645,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时44分，Carisma Therapeutics, Inc.股票出现波动，股价急速下跌5.70%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224405a1f60e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224405a1f60e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2491374395","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491374395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491374395?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:34","pubTimestamp":1734104072,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时34分，Carisma Therapeutics, Inc.股票出现异动，股价急速下挫5.15%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213233432984bd9ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213233432984bd9ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","LENZ","BK4139"],"gpt_icon":0},{"id":"2490820848","title":"美国研究综述-Altus Power、Marsh & Mclennan、TPI 复合材料公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2490820848","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490820848?lang=zh_cn&edition=full","pubTime":"2024-12-12 14:55","pubTimestamp":1733986538,"startTime":"0","endTime":"0","summary":"    路透12月12日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Marsh & Mclennan 和 TPI Composites。要点             * Altus Power Inc   ：摩根大通将其评级从中性下调至减持             * Marsh & Mclennan   ：加拿大皇家银行将其评级从 \"行业表现 \"上调至 \"跑赢大盘\"。* 贝克休斯公司   ：加拿大皇家银行将目标价从43美元上调至49美元             * Blue Owl Capital Corp   ：KBW将目标价从15.50美元下调至14美元             * Blue Owl Capital Corp   ：KBW将其市场表现从 \"跑输大市 \"下调至 \"跑输大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","OBDC","LU0742534661.SGD","BKR","IE00B894F039.SGD","LU1489326972.SGD","RBA","BEPC","BK4567","LU1059921491.USD","LU2326559502.SGD","IE0002270589.USD","CARM","BK4096","LU1633808545.USD","LU1894683264.USD","TOL","ADBE","XEL","LU0889566641.SGD","MAA","LU1551013425.SGD","LU0234572021.USD","LU0198837287.USD","HTGC","DUOL","LU0792757196.USD","LU1366333091.USD","LU1674673691.USD","AMPS","LU0433182093.SGD","LU1861558580.USD","LU2463526074.USD","LU0109391861.USD","LU0965509101.SGD","LU1064131342.USD","LU1623119135.USD","TPIC","CCB","LU2210149790.SGD","AEP","MMC","CMCSA","IE00BK4W5M84.HKD","LU1116320737.USD","INDB","VRT","LU0823411888.USD","TSLA"],"gpt_icon":1},{"id":"2490538863","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490538863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490538863?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:38","pubTimestamp":1733927907,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时38分，Carisma Therapeutics, Inc.股票出现波动，股价急速下跌5.04%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121122382795e8f87a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121122382795e8f87a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2490685014","title":"Carisma Therapeutics, Inc.盘中异动 急速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490685014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490685014?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:34","pubTimestamp":1733841256,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时34分，Carisma Therapeutics, Inc.股票出现异动，股价急速跳水5.26%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223417a1e39979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223417a1e39979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2489914429","title":"Carisma Therapeutics, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489914429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489914429?lang=zh_cn&edition=full","pubTime":"2024-12-05 04:23","pubTimestamp":1733343823,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日04时23分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下挫5.05%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205042344a1d46258&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205042344a1d46258&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2486063108","title":"美国研究综述-多米诺比萨、弹性 NV、雪花","url":"https://stock-news.laohu8.com/highlight/detail?id=2486063108","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486063108?lang=zh_cn&edition=full","pubTime":"2024-11-26 05:38","pubTimestamp":1732570699,"startTime":"0","endTime":"0","summary":"美国研究综述-多米诺比萨、弹性 NV、雪花路透社11月25日 - 华尔街证券分析师周一调整了对多米诺比萨、Elastic NV 和 Snowflake 等几家美国上市公司的评级和目标价。要点 * 多米诺比萨公司DPZ.N：TD Cowen将目标价从475美元上调至515美元 * Elastic NV ESTC.N：Wedbush将其评级从 \"中性 \"上调至 \"跑赢大盘\"。* Thor Industries Inc THO.N：CFRA将目标价从90美元上调至115美元 以下是路透社周一报导的美国公司研究报告摘要。* Edwards Lifesciences Corp EW.N：Leerink Partners将目标价从73美元上调至74美元 * Ehealth Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nL3T3MW0XP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVS","DPZ","AKR","COLB","EW","KR","ACHC","LU0345770993.USD","CSWI","DXLG","LU0072461881.USD","LU1429558221.USD","EWCZ","CARM","BKR","EQT","ADVM","BK","DXCM","BERY","LU2125909759.SGD","DTM","AZEK","LU1861559042.SGD","BK4505","CYH","AMGN","BJ","EDIT","BBIO","LU1548497426.USD","BK4581","DASH","CCAP","EHC","BURL","DE","BK4106","CFLT","ASH","ESTC","CHWY","LU2211817866.USD","BMRN","CRL"],"gpt_icon":1},{"id":"2486802020","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.78%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486802020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486802020?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:35","pubTimestamp":1732545325,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时35分，Carisma Therapeutics, Inc.股票出现异动，股价快速上涨5.78%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522352598e44675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522352598e44675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2483306149","title":"Carisma Therapeutics, Inc.2024财年第三财季实现净利润-12.70百万美元，同比增加40.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306149?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Carisma Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.70百万美元，同比增加40.65%；其中营业收入为3.39百万美元，同比减少11.49%，每股基本收益为-0.31美元。从资产负债表来看，Carisma Therapeutics, Inc.总负债53.18百万美元，其中短期债务2.46百万美元，资产负债比为0.80，流动比率为3.24。机构评级：截至2024年11月16日，当前有4家机构对Carisma Therapeutics, Inc.目标价做出预测，其中目标均价为11.00美元，其中最低目标价为4.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000321a23b89e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000321a23b89e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","LENZ"],"gpt_icon":0},{"id":"2481160031","title":"Carisma Therapeutics Inc    预计每股亏损 26 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481160031","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481160031?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:17","pubTimestamp":1730902648,"startTime":"0","endTime":"0","summary":"   * Carisma Therapeutics Inc    预计将在11月7日公布截至2024年9月30日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收有望从去年同期的383万美元增长42.8%，达到546.7万美元。* LSEG 分析师对 Carisma Therapeutics Inc 的平均预期是每股亏损 26 美分。* 华尔街对 Carisma Therapeutics Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 1.10 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARM","LENZ"],"gpt_icon":0},{"id":"2481538763","title":"Carisma Therapeutics, Inc.盘中异动 急速拉升6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481538763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481538763?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:48","pubTimestamp":1730735312,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时48分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨6.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234832971a4346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234832971a4346&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2479789035","title":"Carisma Therapeutics, Inc.盘中异动 快速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479789035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479789035?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:47","pubTimestamp":1730296043,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时47分，Carisma Therapeutics, Inc.股票出现波动，股价急速上涨5.45%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030214723971a33e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030214723971a33e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2477641535","title":"Carisma Therapeutics, Inc.盘中异动 急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477641535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477641535?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:58","pubTimestamp":1729691896,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时58分，Carisma Therapeutics, Inc.股票出现异动，股价急速上涨5.08%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.28%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023215817971a1d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023215817971a1d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2476175048","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476175048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476175048?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:12","pubTimestamp":1729174332,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时12分，Carisma Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221212971a0db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221212971a0db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2474062034","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474062034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474062034?lang=zh_cn&edition=full","pubTime":"2024-10-09 01:16","pubTimestamp":1728407766,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日01时16分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水5.60%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009011606ab6883b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009011606ab6883b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2471340385","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471340385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471340385?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:36","pubTimestamp":1727703394,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时36分，Carisma Therapeutics, Inc.股票出现波动，股价快速下挫5.46%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302136349719d974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302136349719d974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2460231352","title":"Carisma Therapeutics, Inc.盘中异动 下午盘股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460231352","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460231352?lang=zh_cn&edition=full","pubTime":"2024-08-17 02:37","pubTimestamp":1723833423,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日02时37分，Carisma Therapeutics, Inc.股票出现波动，股价急速拉升5.64%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081702370397198fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081702370397198fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2459714364","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.94%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459714364","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459714364?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:05","pubTimestamp":1723734355,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时05分，Carisma Therapeutics, Inc.股票出现波动，股价快速上涨5.94%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230556a1d474a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230556a1d474a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","stockEarnings":[{"period":"1week","weight":0.0324},{"period":"1month","weight":-0.5154},{"period":"3month","weight":-0.5736},{"period":"6month","weight":-0.5903},{"period":"1year","weight":-0.8559},{"period":"ytd","weight":-0.8574}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CARISMA Therapeutics Inc.于2008年2月25日在特拉华州法律下成立，是一家临床阶段细胞治疗公司，专注于使用专有的CAR-M细胞治疗平台开发变革性免疫疗法来治疗癌症和其他严重疾病。拥有专有的CAR-M细胞治疗平台，该平台通过利用转基因骨髓细胞（巨噬细胞和单核细胞）表达嵌合抗原受体（car）来重定向巨噬细胞对抗特定的肿瘤相关抗原，并实现靶向抗肿瘤免疫，使这些有效的先天免疫细胞能够识别肿瘤细胞表面的特定肿瘤相关抗原。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.118068},{"month":2,"riseRate":0.3,"avgChangeRate":0.03966},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.09024},{"month":4,"riseRate":0.545455,"avgChangeRate":0.307249},{"month":5,"riseRate":0.545455,"avgChangeRate":0.110205},{"month":6,"riseRate":0.727273,"avgChangeRate":0.139785},{"month":7,"riseRate":0.181818,"avgChangeRate":0.036568},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.01952},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.081936},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.064229},{"month":11,"riseRate":0.454545,"avgChangeRate":0.010922},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.050301}],"exchange":"NASDAQ","name":"Carisma Therapeutics","nameEN":"Carisma Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Carisma Therapeutics,CARM,Carisma Therapeutics股票,Carisma Therapeutics股票老虎,Carisma Therapeutics股票老虎国际,Carisma Therapeutics行情,Carisma Therapeutics股票行情,Carisma Therapeutics股价,Carisma Therapeutics股市,Carisma Therapeutics股票价格,Carisma Therapeutics股票交易,Carisma Therapeutics股票购买,Carisma Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}